-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Demystifying Autoimmune HIT: What It Is, When to Test, and How to Treat

Program: Education Program
Session: HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia
Hematology Disease Topics & Pathways:
Education
Saturday, December 7, 2024, 4:00 PM-5:15 PM

Marie Scully, MD

University College London, London, ENG, United Kingdom

Disclosures: Scully: Shire (a Takeda company): Research Funding; Octapharma: Other: received speakers fees; Baxalta (a Takeda company): Research Funding; Sanofi: Other: received speakers fees; Takeda: Honoraria, Other: received speakers fees, Research Funding; Alexion: Other: received speakers fees, Research Funding.

See more of: HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia
See more of: Education Program
<< Previous Presentation | Next Presentation